Covid-19 and acute kidney injury in hospital: summary of NICE guidelines

Abstract

Acute kidney injury (AKI), a sudden reduction in kidney
\nfunction, is seen in some people with covid-19 infection. A
\nsubset of patients develop severe AKI and require renal
\nreplacement therapy (RRT). As in many settings, the
\ndevelopment of AKI is associated with an increased risk of
\nmortality.1 2 Although our understanding is incomplete, a picture is emerging from case reports and autopsy series of covid-19 specific causes of AKI. Intrinsic renal pathology including thrombotic vascular processes, viral mediated tubular cell injury, and glomerulonephritis have been reported, as well as AKI resulting from extrinsic factors such as fluid depletion, multi-organ failure, and rhabdomyolysis.3-7 Anecdotal reports
\nhave emerged of proximal tubular injury with Fanconi syndrome that manifests as hypokalaemia, hypophosphataemia, normal anion gap metabolic acidosis, and hypovolaemia from salt wasting. Importantly, AKI can occur at all stages of covid-19 infection, so clinical vigilance and consideration of risk factors for AKI alongside early detection and diagnosis are essential components of general supportive care. Fluid management is
\ncentral to this. This article summarises key points from the National Institute for Health and Care Excellence (NICE) covid-19 rapid guideline on AKI in hospital.